Operating profit before deduction of amortization: Cabaletta Bio (CABA)
Cabaletta Bio, Inc. (CABA) is developing advanced CARTA cell therapy to combat autoimmune pathologies by investing in bioengineering. The EBITDA reflects cash flow dynamics, where the 0.00 level indicates the current magnitude. The company targets the myasthenia gravis and lupus treatment markets, although the business is currently facing a liquidity shortage due to costly clinical trials.
Cabaletta Bio (CABA) - metric breakdowns and financial figures
- stock value and consensus price forecast:
- company stock exchange capitalization indicators:
- shareholders' equity book value data:
- debt level and financial liquidity data:
Debt to Equity Ratio Cabaletta Bio, Inc.|CABA - Long-Term Debt to Capital|Current Liabilities to Capital Cabaletta Bio Inc.|CABA - Company Aggregate Debts|Debt to Book Value Cabaletta Bio, Inc.|CABA - Company Long-Term Debts|Company Short-Term Debts Cabaletta Bio, Inc.|Quick Liquidity cabalettabio.com
- earnings and multiples data:
CABA - Net Profit|Projected Future Earnings Cabaletta Bio, Inc.|CABA - Price to Earnings Ratio|Future Price to Earnings cabalettabio.com|CABA - PEG Multiple|Company Value to EBITDA Cabaletta Bio, Inc.|CABA - Operating profit before deduction of amortization|Earnings per share for the last four quarters Cabaletta Bio, Inc.|CABA - Net earnings per share for the last 12 months|Year-over-year earnings per share growth rate for the last twelve months cabalettabio.com|CABA - Earnings growth in current year|Earnings growth forecast for next year Cabaletta Bio, Inc.
Summary company analytics:CABA - Cabaletta Bio Inc
This indicator captures actual cash flow from core operations, stripped of non-cash charges, allowing for an objective assessment of the business's operational efficiency. Growth in this metric confirms the commercial viability of Cabaletta Bio (CABA) innovative CAR-T therapies for autoimmune pathologies, while the visualization of EBITDA dynamics helps investors decouple the fundamental trend from short-term market volatility.
Who Cabaletta Bio, Inc. competes with
Operating income before deduction of amortization argenx BVBA (ARGX)|BNTX - Profit before payment of interest, taxes and amortization|Abivax S.A. (ABVX) - Operating profit before deduction of amortization|ADMA Biologics, Inc. (ADMA) - Profit before payment of interest, taxes and amortization|Operating profit before deduction of amortization Protagonist Therapeutics, Inc.|Operating profit before deduction of amortization IMVT|Operating profit EBITDA Kiniksa Corp|Profit before payment of interest, taxes and amortization Grifols, S.A. (GRFS)|adaptivebiotech.com - Operating profit before amortization|Operating profit EBITDA CLDX (Celldex Therapeutics, Inc.)|Aurinia Pharmaceuticals Inc (AUPH) - Profit before interest, taxes and amortization|BioCryst Pharmaceuticals Inc - Operating profit EBITDA|Vera Corp (VERA) - Operating profit before deduction of amortization|DNTH: Operating profit EBITDA|pharvaris.com (PHVS) - Operating profit EBITDA|ABCL (AbCellera Biologics Inc.) - Operating profit EBITDA|Profit before payment of interest, taxes and amortization TRML|Operating profit EBITDA PGEN|Operating profit EBITDA Pharming Corp (PHAR)|Profit before payment of interest, taxes and amortization Nektar Therapeutics NKTR|upstreambio.com - Profit before payment of interest, taxes and amortization|Zenas Biopharma - Operating profit EBITDA|Profit before interest, taxes and amortization Immunome Inc|GOSS (Gossamer Corp) - Operating profit before deduction of amortization|KALV: Company profit before taxes, interest and amortization|Operating profit before deduction of amortization SEPN|PVLA (pieris.com) - Company profit before taxes, interest and amortization|Operating profit EBITDA SVRA|Operating profit EBITDA Rigel Pharma (RIGL)|AnaptysBio Corp - Operating profit before deduction of amortization|Income before deduction of interest, taxes and amortization ATXS|enGene Holdings Inc. - Operating profit EBITDA|RAPT: Profit before payment of interest, taxes and amortization|JBIO: Operating profit EBITDA|ACRS - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization Kyverna|Profit before interest, taxes and amortization Tiziana Life Sciences, Ltd. TLSA|Operating profit before deduction of amortization VTYX (Ventyx Biosciences)|THTX (theratech.com) - Income before deduction of interest, taxes and amortization|Operating profit EBITDA AVTX (Avalo Therapeutics)|Operating income before deduction of amortization Eledon Pharmaceuticals Inc. (ELDN)|AGEN - Profit before payment of interest, taxes and amortization|CLYM (Climb Bio, Inc) - Operating profit before amortization|ZURA: Operating profit EBITDA|Operating profit before deduction of amortization atyrpharma.com|Operating profit before deduction of amortization ADAG|Ikena Oncology, Inc. (IMA) - Operating income before deduction of amortization|Operating profit EBITDA STTK|Operating profit before deduction of amortization equilliumbio.com EQ|Operating profit EBITDA CNTB (Connect Biopharma Holdings Limited)|Operating profit EBITDA Immunic Therapeutics IMUX|Atara Biotherapeutics Inc - Operating profit EBITDA|IFRX: Profit before payment of interest, taxes and amortization|XFOR: Operating profit EBITDA|Adicet Bio, Inc. (ACET) - Operating profit EBITDA|Profit before payment of interest, taxes and amortization Celularity Inc|inmunebio.com - Profit before deduction of interest, taxes, depreciation and amortization|Operating profit EBITDA BRNS|KZR (Kezar Life Sciences Inc.) - Income before deduction of interest, taxes and amortization|Operating profit EBITDA SABS (SAB Biotherapeutics, Inc)|Operating profit EBITDA Akari Therapeutics, Plc AKTX|ENLV - Profit before payment of interest, taxes and amortization|Income before deduction of interest, taxes and amortization QTTB (Q32 Bio Inc.)|GeoVax (GOVX) - Profit before payment of interest, taxes and amortization|Operating profit before deduction of amortization Edesa Biotech Inc|IBIO (iBio Corp) - Operating profit EBITDA|Operating profit EBITDA Carisma Tx|Operating profit before deduction of amortization XTLB (XTL Biopharmaceuticals)|BOLT (boltbio.com) - Income before deduction of interest, taxes and amortization|Operating profit EBITDA HCWB (HCW Biologics)|Operating income before deduction of amortization Aptevo Therapeutics, Inc. (APVO)|AIM - Profit before payment of interest, taxes and amortization|Aditxt (ADTX) - Operating profit before deduction of amortization|GRI Bio, Inc. (GRI) - Profit before payment of interest, taxes and amortization|Operating profit before deduction of amortization xortx.com|Operating profit before deduction of amortization HIND|Operating profit EBITDA Revelation Biosciences Inc|Profit before payment of interest, taxes and amortization Indaptus (INDP)|BiondVax Pharmaceuticals - Operating profit before amortization|Operating profit EBITDA CALI (CalciMedica)|Affimed NV (AFMD) - Profit before interest, taxes and amortization|Allakos Therapeutics - Operating profit EBITDA|HOOKIPA Pharma Inc. (HOOK) - Operating profit before deduction of amortization|IGMS: Operating profit EBITDA|iTeos Pharma (ITOS) - Operating profit EBITDA|OCEA (Ocean Biomedical, Inc.) - Operating profit EBITDA|Profit before payment of interest, taxes and amortization TCBP|Operating profit EBITDA THRD
